- Home
- WKHS vs CRIS Comparison
WKHS vs CRIS Comparison
Compare WKHS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | CRIS |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 14.0M |
| IPO Year | 2008 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WKHS | CRIS |
|---|---|---|
| Price | $2.65 | $0.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $17.00 |
| AVG Volume (30 Days) | 129.6K | ★ 780.6K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.92 | ★ 91.57 |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $9,898,000.00 |
| Revenue This Year | $89.23 | $27.10 |
| Revenue Next Year | $28.84 | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.53 | $0.49 |
| 52 Week High | $11.80 | $3.13 |
Technical Indicators
Market Signals| Indicator | WKHS | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 40.77 | 41.96 |
| Support Level | $2.36 | $0.49 |
| Resistance Level | $3.60 | $0.79 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 48.44 | 33.92 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.